Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center
Alpha Tau Medical has successfully treated the first immunocompromised patient with recurrent cutaneous squamous cell carcinoma (cSCC) in its ADMIRE clinical trial using the Alpha DaRT alpha-radiation therapy. The trial addresses a vulnerable population with limited treatment options due to risks posed by existing therapies like checkpoint inhibito…